Mm. Hsu et al., SOLUBLE INTERLEUKIN-2 RECEPTOR AS A CLINICAL-PARAMETER FOR NASOPHARYNGEAL CARCINOMA, Asian Pacific Journal of Allergy and Immunology, 13(1), 1995, pp. 1-4
We evaluated whether the serum soluble interleukin-2 receptor (sIL-2R)
may be a parameter to monitor the efficacy of treatment for nasophary
ngeal carcinoma (NPC). There were 177 NPC patients and 24 healthy cont
rols. The level of sIL-2R was measured with a sandwich ELISA kit. High
er levels of sIL-2R than for controls were found in NPC patients befor
e treatment and in patients with distant metastasis (p<0.001). There w
as, however, no difference in sIL-2R levels between controls and NPC p
atients after radiotherapy in relapse-free or in primary relapse. The
sIL-2R levels in sequential testing revealed good correlation with cli
nical response. The sIL-2R levels were found to be elevated when dista
nt metastasis was detected. Two patients had elevated sIL-2R level up
to 5 months before clinical detection of metastasis. These results ind
icate that serial measurements of sIL-2R levels are worthwhile for NPC
patients in their clinical course. The sIL-2R level proved to be an a
djunct clinical parameter to monitor the efficacy of treatment of NPC.